Table 2.
Correlates of Hepatocellular Carcinoma Surveillance (N=1137)
| Variable | Multivariate Analysis * |
Percent receiving HCC surveillance during follow-up | |
|---|---|---|---|
| OR | 95% CI | ||
| Etiology of Liver Disease | |||
| Hepatitis C virus | Reference | Reference | 47.7% |
| Hepatitis B virus | 2.72 | 1.28 – 5.81 | 69.4% |
| Alcohol-related | 0.63 | 0.42 – 0.93 | 35.9% |
| NASH | 0.39 | 0.28 – 0.56 | 24.2% |
| Other | 0.45 | 0.31 – 0.64 | 25.2% |
| Child Pugh B or C cirrhosis at baseline | 1.61 | 1.07 – 2.43 | 49.2% vs. 32.8% |
| Receipt of Hepatology care during year prior to index visit | 1.88 | 1.44 – 2.46 | 45.0% vs. 28.4% |
| Baseline AST > 40 U/L | 1.63 | 1.13 – 2.35 | 51.2% vs. 31.8% |
*
Adjusted for age and thrombocytopenia, which were significant on univariate analysis
AST – aspartate aminotransferase; HCC – hepatocellular carcinoma; NASH – nonalcoholic steatohepatitis